Kinase, in vitro: 

An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.

LKB1 T208-p
PKACA S409-p
PKCD T596-p
PKCI T596-p
PKCZ T596-p
PRKD1 S400-p
PRKD2 S400-p
 Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

GSK3B S212-p
LKB1 T208-p
MARK2 S400-p
PKACA S409-p
PKCD T596-p
PKCZ T596-p
Phosphatases, in vitro:
PPP2CB T596-p
Regulatory protein:
GCN2 T596-p
HRI T596-p
HSP90A T596-p
PERK T596-p
PKR T596-p
PLK1 S569-p
SOD1 T596-p
Treatment:
angiotensin_2 S40-p
anti-CD3 S456-p
AZD1152 S479-p , S569-p
dasatinib S486-p
depolarization T596-p
EGF S456-p , S569-p , S571-p , S619-p
ephrin_B1 Y613-p
ephrin_B2 Y613-p
geldanamycin T596-p
H-89 S409-p
ischemia S619-p , S631-p
lapatinib S40-p
LRRK2-IN-1 S456-p , S571-p , S631-p
MG132 T596-p
MG132_withdrawal S390-p , S569-p
NaAsO2 T596-p
NKH_477 S409-p
nocodazole S486-p , S493-p , S619-p
okadaic_acid T596-p
phorbol_ester S400-p
selumetinib S43-p
SII_angiotensin_2 S40-p
thymidine S486-p , S493-p
tunicamycin T596-p
vemurafenib S43-p
Y27632 T208-p , S595-p
ZM447439 S479-p , S569-p